Skip to content
← Myelodysplastic Syndromes

FOR PATIENTS · SOURCE READING

Treatment of Myelodysplastic Syndromes

Source: Myelodysplastic Syndromes Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: October 4, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

For information about the treatments listed below, see the Treatment Option Overview section.

Source links and citations

The treatment of myelodysplastic syndromes may include the following:

Source links and citations

Supportive care with one or more of the following:

Source links and citations

Supportive care with one or more of the following:

Transfusion therapy.

Source links and citations

Supportive care with one or more of the following:

Erythropoiesis-stimulating agents.

Source links and citations

Supportive care with one or more of the following:

Antibiotic therapy.

Source links and citations

Treatments to slow progression to acute myeloid leukemia (AML):

Source links and citations

Treatments to slow progression to acute myeloid leukemia (AML):

Lenalidomide.

Source links and citations

Treatments to slow progression to acute myeloid leukemia (AML):

Immunosuppressive therapy.

Source links and citations

Treatments to slow progression to acute myeloid leukemia (AML):

Azacitidine and decitabine.

Source links and citations

Treatments to slow progression to acute myeloid leukemia (AML):

Chemotherapy used in acute myeloid leukemia.

Source links and citations

Chemotherapy with stem cell transplant.

Source links and citations

Patients who were treated in the past with chemotherapy or radiation therapy may develop myeloid neoplasms related to that therapy. Treatment options are the same as for other myelodysplastic syndromes.

Source links and citations

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice